Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 23907646)

1.

Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children.

Kemper AR, Green NS, Calonge N, Lam WK, Comeau AM, Goldenberg AJ, Ojodu J, Prosser LA, Tanksley S, Bocchini JA Jr.

Genet Med. 2014 Feb;16(2):183-7. doi: 10.1038/gim.2013.98. Epub 2013 Aug 1.

PMID:
23907646
2.

Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children.

Calonge N, Green NS, Rinaldo P, Lloyd-Puryear M, Dougherty D, Boyle C, Watson M, Trotter T, Terry SF, Howell RR; Advisory Committee on Heritable Disorders in Newborns and Children.

Genet Med. 2010 Mar;12(3):153-9. doi: 10.1097/GIM.0b013e3181d2af04.

PMID:
20154628
3.
4.

Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders.

Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2012 Apr 6;61(RR-2):1-44.

5.

Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening.

Therrell BL Jr, Hannon WH, Bailey DB Jr, Goldman EB, Monaco J, Norgaard-Pedersen B, Terry SF, Johnson A, Howell RR.

Genet Med. 2011 Jul;13(7):621-4. doi: 10.1097/GIM.0b013e3182147639.

PMID:
21602691
6.

Including the initial newborn screening bloodspot collection device serial number on birth certificates: basis and recommendations from the Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children.

Therrell BL, Wu C; Secretary of Health and Human Services Advisory Committee on Heritable Disorders in Newborns and Children; SACHDNC Subcommittee on Long Term Follow-up and Treatment.

Genet Med. 2013 Mar;15(3):229-33. doi: 10.1038/gim.2012.121. Epub 2012 Oct 4.

PMID:
23037933
7.

Committee Report: advancing the current recommended panel of conditions for newborn screening.

Green NS, Rinaldo P, Brower A, Boyle C, Dougherty D, Lloyd-Puryear M, Mann MY, Howell RR; Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children.

Genet Med. 2007 Nov;9(11):792-6.

PMID:
18007148
8.

What questions should newborn screening long-term follow-up be able to answer? A statement of the US Secretary for Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children.

Hinton CF, Feuchtbaum L, Kus CA, Kemper AR, Berry SA, Levy-Fisch J, Luedtke J, Kaye C, Boyle CA.

Genet Med. 2011 Oct;13(10):861-5. doi: 10.1097/GIM.0b013e3182209f09.

PMID:
21716119
9.

Long-term follow-up after diagnosis resulting from newborn screening: statement of the US Secretary of Health and Human Services' Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children.

Kemper AR, Boyle CA, Aceves J, Dougherty D, Figge J, Fisch JL, Hinman AR, Greene CL, Kus CA, Miller J, Robertson D, Telfair J, Therrell B, Lloyd-Puryear M, van Dyck PC, Howell RR.

Genet Med. 2008 Apr;10(4):259-61. doi: 10.1097/GIM.0b013e31816b64f9. Erratum in: Genet Med. 2008 May;10(5):368. Telfair, Joseph [added].

PMID:
18414208
10.

Newborn screening: education, consent, and the residual blood spot. The position of the national society of genetic counselors.

Blout C, Walsh Vockley C, Gaviglio A, Fox M, Croke B, Williamson Dean L; Newborn Screening Task Force on behalf of the NSGC Public Policy Committee.

J Genet Couns. 2014 Feb;23(1):16-9. doi: 10.1007/s10897-013-9631-1. Epub 2013 Jul 24.

PMID:
23881473
11.

Secretary's Advisory Committee on Heritable Disorders in Newborns and Children response to the President's Council on Bioethics report: the changing moral focus of newborn screening.

Trotter TL, Fleischman AR, Howell RR, Lloyd-Puryear M; Secretary's Advisory Committee on Heritable Disorders in Newborns and Children.

Genet Med. 2011 Apr;13(4):301-4. doi: 10.1097/GIM.0b013e318210655d. No abstract available.

PMID:
21407080
12.

Advisory committee on heritable disorders and genetic diseases in newborns and children.

Howell RR; Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children.

Ment Retard Dev Disabil Res Rev. 2006;12(4):313-5. No abstract available.

PMID:
17183571
13.

Newborn screening for critical congenital heart disease: potential roles of birth defects surveillance programs--United States, 2010-2011.

Centers for Disease Control and Prevention.

MMWR Morb Mortal Wkly Rep. 2012 Oct 26;61(42):849-53.

14.

A framework for key considerations regarding point-of-care screening of newborns.

Kemper AR, Kus CA, Ostrander RJ, Comeau AM, Boyle CA, Dougherty D, Mann MY, Botkin JR, Green NS; United States Secretary of Health and Human Services Advisory Committee.

Genet Med. 2012 Dec;14(12):951-4. doi: 10.1038/gim.2012.89. Epub 2012 Aug 16.

PMID:
22899090
15.

Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.

De Jesús VR, Adam BW, Mandel D, Cuthbert CD, Matern D.

Mol Genet Metab. 2014 Sep-Oct;113(1-2):67-75. doi: 10.1016/j.ymgme.2014.07.010. Epub 2014 Jul 17.

PMID:
25066104
16.

Impact of expanded newborn screening--United States, 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Sep 19;57(37):1012-5.

17.

Strategies for implementing screening for critical congenital heart disease.

Kemper AR, Mahle WT, Martin GR, Cooley WC, Kumar P, Morrow WR, Kelm K, Pearson GD, Glidewell J, Grosse SD, Howell RR.

Pediatrics. 2011 Nov;128(5):e1259-67. doi: 10.1542/peds.2011-1317. Epub 2011 Oct 10.

18.
19.

Analysis: Secretary's Advisory Committee on Genetics, Health, and Society Report falls short.

Klein RD.

Hum Pathol. 2009 Feb;40(2):147-55. doi: 10.1016/j.humpath.2008.09.007. Epub 2008 Dec 11.

PMID:
19084265
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk